Advances in the experimental and clinical research of pemetrexed
- VernacularTitle:培美曲塞的实验和临床研究进展
- Author:
Dan HONG
;
Yiping ZHANG
- Publication Type:Journal Article
- Keywords:
pemetrexed;
maligmant pleural mesothelioma;
NSCLC;
breast cancer;
panereatic caner
- From:
China Oncology
1998;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
Pemetrexed is a multitargeted anti-metabolite.Pemetrexed has been approved as first-line treatment in malignant pleural mesothelioma(MPM)and second-line treatment in non-small cell lung cancer(NSCLC).A lot of experimental and clinical trials on pemetrexed have been conducted for the treatment of several kinds of cancer now.This paper summarizes the current developments in experimental and clinical research.
